Palisade Bio Inc (NASDAQ: PALI) on Monday, plunged -6.34% from the previous trading day, before settling in for the closing price of $0.79. Within the past 52 weeks, PALI’s price has moved between $0.60 and $4.32.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 77.35% over the last five years. The company achieved an average annual earnings per share of 84.60%. With a float of $4.76 million, this company’s outstanding shares have now reached $4.80 million.
The firm has a total of 8 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Palisade Bio Inc (PALI) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Palisade Bio Inc is 0.81%, while institutional ownership is 5.43%.
Palisade Bio Inc (PALI) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -2.32 earnings per share (EPS) for the period topping the consensus outlook (set at -3.36) by 1.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 84.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 51.86% during the next five years compared to 77.35% growth over the previous five years of trading.
Palisade Bio Inc (NASDAQ: PALI) Trading Performance Indicators
Palisade Bio Inc (PALI) is currently performing well based on its current performance indicators. A quick ratio of 2.81 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.90, a number that is poised to hit -0.56 in the next quarter and is forecasted to reach -1.21 in one year’s time.
Technical Analysis of Palisade Bio Inc (PALI)
Analysing the last 5-days average volume posted by the [Palisade Bio Inc, PALI], we can find that recorded value of 19.95 million was better than the volume posted last year of 1.17 million. As of the previous 9 days, the stock’s Stochastic %D was 2.38%.
During the past 100 days, Palisade Bio Inc’s (PALI) raw stochastic average was set at 10.77%, which indicates a significant increase from 2.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2251 in the past 14 days, which was higher than the 0.0823 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8067, while its 200-day Moving Average is $1.2835. Now, the first resistance to watch is $0.7960. This is followed by the second major resistance level at $0.8520. The third major resistance level sits at $0.8935. If the price goes on to break the first support level at $0.6985, it is likely to go to the next support level at $0.6570. Now, if the price goes above the second support level, the third support stands at $0.6010.
Palisade Bio Inc (NASDAQ: PALI) Key Stats
Market capitalization of the company is 3.55 million based on 4,796K outstanding shares. Right now, sales total 0 K and income totals -14,440 K. The company made 0 K in profit during its latest quarter, and -2,230 K in sales during its previous quarter.
